However, lipid and glucose metabolic disorders did not occur in either Ang II- or TAC-induced cardiac hypertrophy models of WT and ANGPTL8 KO mice in our experiment; therefore, ANGPTL8 may act directly on the heart muscle to inhibit cardiac hypertrophy. Here, AGT is linked to glucose metabolism disease.